Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -23.00
- Piotroski Score 3.00
- Grade Neutral
- Symbol (ACOR)
- Company Acorda Therapeutics, Inc.
- Price $0.66
- Changes Percentage (-24.02%)
- Change -$0.21
- Day Low $0.61
- Day High $0.85
- Year High $24.20
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS product for the treatment of acute migrain; rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 05/01/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$203.57
- Trailing P/E Ratio -0.0032470403301076
- Forward P/E Ratio -0.0032470403301076
- P/E Growth -0.0032470403301076
- Net Income $-252,854,000
Income Statement
Quarterly
Annual
Latest News of ACOR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
IDA Stock Price | IDACORP Inc. Stock Quote (U.S.: NYSE) | MarketWatch
IDACORP, Inc. is a holding company involved in the generation, transmission, distribution, and sale of electric energy. It operates through Utilities Operations and All Other segments, focusing on ele...
By MarketWatch | 1 week ago -
What Is Acorns: The Investment App Designed To Make Investing Easy
Acorns is an investment app focused on passive investing and financial simplicity. It automates investing through features like Round Ups and offers various subscription plans tailored to different ne...
By Forbes | 1 month ago -
SEACOR Marine Holdings Inc. (NYSE:SMHI) Analysts Are Pretty Bullish On The Stock After Recent Results
SEACOR Marine Holdings Inc. (NYSE:SMHI) stock dropped 20% to US$11.25 after its latest quarterly results, showing an increase in losses. Analysts forecast revenue growth but expect losses to rise. The...
By Yahoo! Finance | 1 month ago